Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [QUIET] · [HEALTH]

2 clusters · 5 sources · 3 days · First seen about 1 month ago · Last updated 29 days ago

Remedica pharmaceutical product recalls in Cyprus

Overview

A voluntary recall of pharmaceutical products by Remedica has caused disruptions in the Cyprus General Healthcare System (GeSY). The recall has impacted doctors, pharmacists, and patients, particularly as many medical professionals are on summer leave. While the Health Insurance Organisation (OAY) has attempted to facilitate direct replacements for medications with catalog equivalents, cases without alternatives require doctors to re-evaluate patient treatments.

Following the initial disruption, the National Organization for Medicines (EOF) initiated a recall of 39 batches of two specific products: CLONOTRIL TABLET 2MG/TAB and METHYLDOPA/REMEDICA F. C. TAB 250MG/TAB, used to treat epilepsy and hypertension. The recall was prompted by stability monitoring programs showing that certain batches failed to maintain required physicochemical specifications throughout their intended shelf life. EOF has instructed the immediate withdrawal of these specific batches from the market.

Entities

Cyprus Authorities · Remedica Ltd · National Organization for Medicines · GeSY · Cyprus

Timeline

29 days ago

[HEALTH] 3 sources
National Organization for Medicines recalls 39 batches of epilepsy and hypertension drugs
The National Organization for Medicines is recalling 39 batches of epilepsy and hypertension drugs manufactured by Remedica Ltd due to stability concerns identified during monitoring.
about 1 month ago

[HEALTH] 2 sources
Remedica drug recalls cause disruption in Cyprus healthcare system
Remedica's voluntary drug recall is causing disruptions in Cyprus's GeSY healthcare system, requiring doctors to adjust prescriptions and OAY to secure alternative medical stocks.

Sources

alfavita.gr · dialogos.com.cy · hellenicshippingnews.com · omegalive.com.cy · thestival.gr